
|Articles|February 1, 2002
Power modulation upgrade takes phaco to new level
New Orleans-WhiteStar, the new power modulation technology for the Sovereign System (Allergan), affords phacoemulsification surgeons improved intraoperative control and optimizes outcomes for patients, with clearer corneas on postoperative day 1, said Lisa Brothers Arbisser, MD, at the annual meeting of the American Academy of Ophthalmology here last fall.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Advancements in laser refractive surgery
2
From then to next: Five decades of transformation in ophthalmology
3
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
4
Q&A: Advancing a long-acting anti-VEGF candidate: What it means for retinal disease
5


















































.png)


